Virtus LifeSci Biotech Clinical Trials ETF Rating → The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (From Smallcaps Daily) (Ad) Free BBC Stock Alerts $28.10 +0.14 (+0.50%) (As of 05/7/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsRatingsStock AnalysisChartHoldingsRatings Virtus LifeSci Biotech Clinical Trials ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBC Aggregate RatingModerate Buy2.84Holdings in BBC have an aggregate rating of Moderate Buy based on 344 analyst ratings issued in the past year covering 49 companies (65.1% of the portfolio).BBC Aggregate Price Target$43.3954.41% UpsideHigh Prediction$62.62Average Prediction$43.39Low Prediction$27.28Holdings in BBC have an aggregate price target of $43.39 and a range of $27.28 to $62.62 covering 49 companies (65.1% of the portfolio).BBC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy24 Buy rating(s)Moderate Buy21 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Clinical Trials ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 49 BBC Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.18%VKTXViking Therapeutics$79.61+1.8%4 of 5 stars3.00$112.25 41.0%102.74%ALPNAlpine Immune Sciences$64.64+0.1%2 of 5 stars2.27$50.33 -22.1%11Upcoming Earnings2.64%CGEMCullinan Oncology$29.35+3.3%1 of 5 stars3.00$31.00 5.6%7Upcoming Earnings2.57%RNAAvidity Biosciences$25.39-3.6%1 of 5 stars3.00$36.86 45.2%7Upcoming EarningsInsider Selling2.30%VERAVera Therapeutics$45.00-1.2%1 of 5 stars3.00$32.29 -28.3%8Upcoming Earnings1.93%SANASana Biotechnology$10.04+0.4%1 of 5 stars2.75$11.67 16.2%4Upcoming Earnings1.83%SYRESpyre Therapeutics$34.24-4.3%0 of 5 stars3.00$41.00 19.7%8Upcoming Earnings1.75%APGEApogee Therapeutics$52.22-3.8%2 of 5 stars3.00$71.83 37.6%71.75%DYNDyne Therapeutics$25.65-2.3%3 of 5 stars3.13$37.75 47.2%8Analyst Forecast1.68%IBRXImmunityBio$8.26+5.8%0 of 5 stars2.00$6.00 -27.4%1Upcoming EarningsGap Up1.49%MRUSMerus$48.73+2.9%1 of 5 stars3.00$56.33 15.6%11Upcoming Earnings1.48%GERNGeron$3.87+3.8%4 of 5 stars2.80$6.10 57.6%5Analyst Revision1.45%LQDALiquidia$12.84+1.2%2 of 5 stars2.60$21.00 63.6%5Upcoming EarningsPositive News1.42%SMMTSummit Therapeutics$5.31+18.8%2 of 5 stars3.00$7.50 41.2%2Analyst ForecastNews CoverageGap UpHigh Trading Volume1.38%CYTKCytokinetics$65.28+0.4%4 of 5 stars2.87$79.33 21.5%15Insider Selling1.37%KROSKeros Therapeutics$58.68-2.6%3 of 5 stars3.00$86.00 46.6%7Upcoming EarningsNews Coverage1.36%KURAKura Oncology$21.07+0.3%3 of 5 stars2.88$28.28 34.2%8Earnings ReportAnalyst Forecast1.34%MGNXMacroGenics$16.05-2.0%4 of 5 stars2.89$18.00 12.1%9Upcoming Earnings1.30%IOVAIovance Biotherapeutics$13.98+0.7%5 of 5 stars3.00$24.64 76.2%10Upcoming EarningsOptions Volume1.29%BCYCBicycle Therapeutics$23.08-0.9%2 of 5 stars2.86$46.86 103.0%7Earnings Report1.24%MLYSMineralys Therapeutics$14.17+3.1%3 of 5 stars3.00$33.50 136.4%3Upcoming EarningsHigh Trading Volume1.22%FDMT4D Molecular Therapeutics$26.80+0.1%2 of 5 stars3.00$44.22 65.0%10Gap Down1.19%RVMDRevolution Medicines$38.88-0.4%3 of 5 stars3.10$41.20 6.0%10Upcoming EarningsPositive News1.17%NRIXNurix Therapeutics$14.16+7.1%2 of 5 stars2.83$21.33 50.7%61.17%IGMSIGM Biosciences$9.93-1.0%4 of 5 stars2.50$17.44 75.7%8Upcoming Earnings1.14%KYMRKymera Therapeutics$38.44+0.4%0 of 5 stars2.50$41.10 6.9%12Earnings Report1.12%COGTCogent Biosciences$7.76+2.5%1 of 5 stars2.71$13.67 76.1%7Upcoming EarningsNews Coverage1.10%KRYSKrystal Biotech$161.76+3.1%4 of 5 stars3.00$171.00 5.7%9Earnings ReportAnalyst ForecastNews Coverage1.09%ANABAnaptysBio$25.68-0.3%3 of 5 stars2.80$46.22 80.0%10Upcoming Earnings1.03%ALXOALX Oncology$17.56+11.3%1 of 5 stars2.83$18.83 7.3%6Upcoming EarningsHigh Trading Volume1.03%CRNXCrinetics Pharmaceuticals$47.66+2.5%4 of 5 stars2.91$54.00 13.3%12Upcoming EarningsAnalyst ForecastGap Up1.02%SLNOSoleno Therapeutics$46.80+1.9%3 of 5 stars3.00$55.60 18.8%5Upcoming Earnings1.00%INBXInhibrx$34.39+0.3%2 of 5 stars2.00$27.00 -21.5%2Upcoming EarningsPositive News0.99%PTGXProtagonist Therapeutics$25.79-1.0%1 of 5 stars3.00$36.00 39.6%4Upcoming EarningsNews Coverage0.99%DAWNDay One Biopharmaceuticals$17.08+2.9%3 of 5 stars2.86$37.67 120.5%7Analyst ForecastNews Coverage0.96%IDYAIDEAYA Biosciences$42.75-0.8%3 of 5 stars3.00$46.60 9.0%12Upcoming EarningsNews Coverage0.92%LYELLyell Immunopharma$2.542 of 5 stars2.50$5.50 116.5%2Analyst ForecastNews CoverageGap Down0.91%ARDXArdelyx$9.31+1.7%5 of 5 stars3.11$12.81 37.6%9Earnings ReportInsider SellingAnalyst Revision0.90%XNCRXencor$24.24-0.3%4 of 5 stars2.89$36.00 48.5%9Upcoming Earnings0.89%PGENPrecigen$1.38-4.2%3 of 5 stars2.33$10.00 624.6%30.88%SNDXSyndax Pharmaceuticals$23.18+3.0%3 of 5 stars2.90$34.42 48.5%10Upcoming EarningsGap Down0.88%ITOSiTeos Therapeutics$12.31-0.8%1 of 5 stars3.00$30.33 146.4%30.88%IMTXImmatics$10.72-0.2%0 of 5 stars3.001News Coverage0.88%CMPSCOMPASS Pathways$8.54-0.8%1 of 5 stars3.00$47.40 455.0%5Upcoming Earnings0.87%CLDXCelldex Therapeutics$42.21+1.3%1 of 5 stars2.80$66.00 56.4%5Analyst ForecastNews Coverage0.86%ALLOAllogene Therapeutics$2.91-3.3%2 of 5 stars2.71$13.50 363.9%7Upcoming Earnings0.85%BHVNBiohaven$41.49+0.7%3 of 5 stars3.00$52.13 25.6%8Upcoming Earnings0.84%PCVXVaxcyte$67.52+1.7%1 of 5 stars3.00$78.50 16.3%4Upcoming Earnings0.83%PHATPhathom Pharmaceuticals$10.24-5.5%2 of 5 stars2.80$22.00 114.8%5Upcoming EarningsNews Coverage This page (NYSEARCA:BBC) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyAI “wealth window” is closing June 25thParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Clinical Trials ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
